In Vitro and in Vivo RNA Inhibition by CD9-HuR Functionalized Exosomes Encapsulated with miRNA or CRISPR/dCas9
Abstract
In vitro and in vivo delivery of RNAs of interest holds promise for gene therapy. Recently, exosomes are considered as a kind of rational vehicle for RNA delivery, especially miRNA and/or siRNA, while the loading efficiency is limited. In this study, we engineered the exosomes for RNA loading by constructing a fusion protein in which the exosomal membrane protein CD9 was fused with RNA binding protein, while the RNA of interest either natively harbors or is engineered to have the elements for the binding. By proof-of-principle experiments, we here fused CD9 with HuR, an RNA binding protein interacting with miR-155 with a relatively high affinity. In the exosome packaging cells, the fused CD9-HuR successfully enriched miR-155 into exosomes when miR-155 was excessively expressed. Moreover, miR-155 encapsulated in the exosomes in turn could be efficiently delivered into the recipient cells and recognized the endogenous targets. In addition, we also revealed that the CD9-HuR exosomes could enrich the functional miRNA inhibitor or CRISPR/dCas9 when the RNAs were engineered to have the AU rich elements. Taken together, we here have established a novel strategy for enhanced RNA cargo encapsulation into engineered exosomes, which in turn functions in the recipient cells.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
CD9-HuR fusion protein effectively enriched exosomes with miR-155 when miR-155 was overexpressed.
“In exosome-producing cells, the CD9-HuR fusion protein effectively enriched exosomes with miR-155 when miR-155 was overexpressed.”
From Exosome for mRNA delivery: Strategies and therapeutic applications (2024) · cites this paper as [105]
miR-155 encapsulated in these exosomes can be efficiently delivered to recipient cells and target endogenous molecules.
“Moreover, miR-155 encapsulated in these exosomes can be efficiently delivered to recipient cells and target endogenous molecules (Fig. 2C) [105].”
From Exosome for mRNA delivery: Strategies and therapeutic applications (2024) · cites this paper as [105]
Cites
Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes
Alvarez-Erviti, L., Seow, Y., Yin, H., Betts, C., Lakhal, S., & Wood, M. J. A. (2011) · Nature Biotechnology · doi:10.1038/nbt.1807 · Cited by 4,930 · see citing works
Extracellular vesicles: biology and emerging therapeutic opportunities
Andaloussi, S. E., Mäger, I., Breakefield, X. O., & Wood, M. J. A. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3978 · Cited by 3,488 · see citing works
Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex
Konermann, S., Brigham, M. D., Trevino, A. E., Joung, J., Abudayyeh, O. O., Barcena, C., Hsu, P. D., Habib, N., Gootenberg, J. S., Nishimasu, H., et al. (2015) · Nature · doi:10.1038/nature14136 · Cited by 2,825 · see citing works
Exosome and Exosomal MicroRNA: Trafficking, Sorting, and Function
Zhang, J., Li, S., Li, L., Li, M., Guo, C., Yao, J., & Mi, S. (2015) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2015.02.001 · Cited by 2,189 · see citing works
Tian, Y., Li, S., Song, J., Ji, T., Zhu, M., Anderson, G. J., Wei, J., & Nie, G. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.11.083 · Cited by 1,809 · see citing works
Ambros, V. (2001) · Cell · doi:10.1016/s0092-8674(01)00616-x · Cited by 1,704 · see citing works
Systemically Injected Exosomes Targeted to EGFR Deliver Antitumor MicroRNA to Breast Cancer Cells
Ohno, S.-I., Takanashi, M., Sudo, K., Ueda, S., Ishikawa, A., Matsuyama, N., Fujita, K., Mizutani, T., Ohgi, T., Ochiya, T., et al. (2013) · Molecular Therapy · doi:10.1038/mt.2012.180 · Cited by 1,666 · see citing works
LncRNA: A link between RNA and cancer
Yang, G., Lu, X., & Yuan, L. (2014) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2014.08.012 · Cited by 992 · see citing works
Self-citationLu, L., Thai, T., Calado, D. P., Chaudhry, A., Kubo, M., Tanaka, K., Loeb, G. B., Lee, H., Yoshimura, A., Rajewsky, K., et al. (2009) · Immunity · doi:10.1016/j.immuni.2008.11.010 · Cited by 784 · see citing works
Hurley, J. H. (2015) · The EMBO Journal · doi:10.15252/embj.201592484 · Cited by 668 · see citing works
Kooijmans, S. A. A., Stremersch, S., Braeckmans, K., de Smedt, S. C., Hendrix, A., Wood, M. J. A., Schiffelers, R. M., Raemdonck, K., & Vader, P. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.08.014 · Cited by 663 · see citing works
Exosome–Liposome Hybrid Nanoparticles Deliver CRISPR/Cas9 System in MSCs
Lin, Y., Wu, J., Gu, W., Huang, Y., Tong, Z., Huang, L., & Tan, J. (2018) · Advanced Science · doi:10.1002/advs.201700611 · Cited by 625 · see citing works
Re-Engineering Extracellular Vesicles as Smart Nanoscale Therapeutics
Armstrong, J. P. K., Holme, M. N., & Stevens, M. M. (2017) · ACS Nano · doi:10.1021/acsnano.6b07607 · Cited by 605 · see citing works
Santangelo, L., Giurato, G., Cicchini, C., Montaldo, C., Mancone, C., Tarallo, R., Battistelli, C., Alonzi, T., Weisz, A., & Tripodi, M. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.09.031 · Cited by 600 · see citing works
Turturici, G., Tinnirello, R., Sconzo, G., & Geraci, F. (2014) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00228.2013 · Cited by 483 · see citing works
Exosomes: Mechanisms of Uptake
McKelvey, K. J., Powell, K., Ashton, A. W., Morris, J. M., & McCracken, S. A. (2015) · Journal of Circulating Biomarkers · doi:10.5772/61186 · Cited by 421 · see citing works
Wu, B., Su, S., Patil, D. P., Liu, H., Gan, J., Jaffrey, S. R., & Ma, J. (2018) · Nature Communications · doi:10.1038/s41467-017-02770-z · Cited by 389 · see citing works
The pro-inflammatory effects of miR-155 promote liver fibrosis and alcohol-induced steatohepatitis
Bala, S., Csák, T., Saha, B., Zatsiorsky, J., Kodys, K., Catalano, D. E., Satishchandran, A., & Szabó, G. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.01.035 · Cited by 305 · see citing works
Posttranslational control of HuR function
Grammatikakis, I., Abdelmohsen, K., & Gorospe, M. (2016) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1372 · Cited by 237 · see citing works
Highlights of a new type of intercellular communication: microvesicle-based information transfer
Pap, E., Pállinger, É., Pásztói, M., & Falus, A. (2009) · Inflammation Research · doi:10.1007/s00011-008-8210-7 · Cited by 205 · see citing works
Development of exosome surface display technology in living human cells
Stickney, Z., Losacco, J., McDevitt, S., Zhang, Z., & Lü, B. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.02.058 · Cited by 200 · see citing works
Yan, X.-L., Jia, Y.-L., Chen, L., Zeng, Q., Zhou, J.-N., Fu, C.-J., Chen, H.-X., Yuan, H.-F., Li, Z.-W., Shi, L., et al. (2013) · Hepatology · doi:10.1002/hep.26257 · Cited by 185 · see citing works
Self-citationRNA Binding Protein Regulation and Cross-Talk in the Control of AU-rich mRNA Fate
García‐Mauriño, S. M., Rivero-Rodríguez, F., Velázquez‐Cruz, A., Hernández‐Vellisca, M., Dı́az-Quintana, A., la Rosa, M. Á. D., & Díaz‐Moreno, I. (2017) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2017.00071 · Cited by 172 · see citing works
Nanoscale platforms for messenger RNA delivery
Li, B., Zhang, X., & Dong, Y. (2019) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1530 · Cited by 170 · see citing works
MicroRNAs: key participants in gene regulatory networks
Ke, X., Liu, C., Liu, D., & Liang, C. (2003) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(03)00075-9 · Cited by 125 · see citing works
The Impact of the CD9 Tetraspanin on Lentivirus Infectivity and Exosome Secretion
Böker, K. O., Lemus-Diaz, N., Ferreira, R. R., Schiller, L. T., Schneider, S., & Gruber, J. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.11.008 · Cited by 119 · see citing works
Engineering Delivery Vehicles for Genome Editing
Nelson, C. E., & Gersbach, C. A. (2016) · Annual Review of Chemical and Biomolecular Engineering · doi:10.1146/annurev-chembioeng-080615-034711 · Cited by 118 · see citing works
Kossinova, O. A., Gopanenko, A. V., TAMKOVICH, S. N., Krasheninina, O. A., Tupikin, A. E., Владимировна, К. Е., Yanshina, D. D., Malygin, A. A., Ven'yaminova, A. G., Kabilov, M. R., et al. (2017) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2017.03.010 · Cited by 97 · see citing works
Csák, T., Bala, S., Lippai, D., Kodys, K., Catalano, D. E., Iracheta‐Vellve, A., & Szabó, G. (2015) · PLoS ONE · doi:10.1371/journal.pone.0129251 · Cited by 90 · see citing works
Expression of microRNA‐155 in inflammatory cells modulates liver injury
Blaya, D., Aguilar‐Bravo, B., Hao, F., Casacuberta‐Serra, S., Coll, M., Perea, L., Vallverdú, J., Graupera, I., Pose, E., Llovet, L. P., et al. (2018) · Hepatology · doi:10.1002/hep.29833 · Cited by 69 · see citing works
Enhanced production of exosome-associated AAV by overexpression of the tetraspanin CD9
Schiller, L. T., Lemus-Diaz, N., Rinaldi Ferreira, R., Böker, K. O., & Gruber, J. (2018) · Molecular Therapy - Methods & Clinical Development · doi:10.1016/j.omtm.2018.03.008 · Cited by 63 · see citing works
siRNA in ovarian cancer – Delivery strategies and targets for therapy
van den Brand, D., Mertens, V., Massuger, L. F. A. G., & Brock, R. E. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.05.012 · Cited by 59 · see citing works
Therapeutic potentials of short interfering RNAs
Tam, C., Wong, J. H., Cheung, R. C. F., Zuo, T., & Ng, T. B. (2017) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-017-8433-z · Cited by 27 · see citing works
(2013) · doi:10.1093/nar/gkt1181
Flagged first, then by citations
Cited by
Sorted by citations
Zhang, Y., Bi, J., Huang, J., Tang, Y., Du, S., & Li, P. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s264498 · Cited by 1,323 · see citing works
CRISPR/Cas9 therapeutics: progress and prospects
Li, T., Yang, Y., Qi, H., Cui, W., Zhang, L., Fu, X., He, X., Liu, M., Li, P., & Yu, T. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01309-7 · Cited by 770 · see citing works
Meng, W., He, C., Hao, Y., Wang, L., Li, L., & Zhu, G. (2020) · Drug Delivery · doi:10.1080/10717544.2020.1748758 · Cited by 618 · see citing works
Salunkhe, S. A., Dheeraj, Basak, M., Chitkara, D., & Mittal, A. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.07.042 · Cited by 501 · see citing works
Engineered exosomes from different sources for cancer-targeted therapy
Zhang, M. H., Hu, S., Liu, L., Dang, P., Liu, Y., Sun, Z., Qiao, B., & Wang, C. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01382-y · Cited by 487 · see citing works
Exosome engineering: Current progress in cargo loading and targeted delivery
Fu, S., Wang, Y., Xia, X., & Zheng, J. C. (2020) · NanoImpact · doi:10.1016/j.impact.2020.100261 · Cited by 444 · see citing works
Engineered Extracellular Vesicles for Cancer Therapy
Zhang, X., Zhang, H., Gu, J., Zhang, J., Shi, H., Qian, H., Wang, D., Xu, W., Pan, J., & Santos, H. A. (2021) · Advanced Materials · doi:10.1002/adma.202005709 · Cited by 428 · see citing works
Regulation of cargo selection in exosome biogenesis and its biomedical applications in cancer
Lee, Y. J., Shin, K. J., & Chae, Y. C. (2024) · Experimental & Molecular Medicine · doi:10.1038/s12276-024-01209-y · Cited by 430 · see citing works
Therapeutic roles of mesenchymal stem cell-derived extracellular vesicles in cancer
Weng, Z., Zhang, B., Wu, C., Yu, F., Han, B. R., Li, B., & Li, L. (2021) · Journal of Hematology & Oncology · doi:10.1186/s13045-021-01141-y · Cited by 418 · see citing works
Liang, Y., Xu, X., Li, X., Xiong, J., Li, B., Duan, L., Wang, D., & Xia, J. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c10458 · Cited by 391 · see citing works
Nanoparticle Delivery of CRISPR/Cas9 for Genome Editing
Duan, L., Ouyang, K., Xu, X. G., Xu, L., Wen, C., Zhou, X., Qin, Z., Xu, Z., Sun, W., & Liang, Y. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.673286 · Cited by 400 · see citing works
Self-citationExtracellular vesicles: A bright star of nanomedicine
Wu, P., Zhang, B., Ocansey, D. K. W., Xu, W., & Qian, H. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2020.120467 · Cited by 368 · see citing works
Exosome engineering in cell therapy and drug delivery
Sadeghi, S., Tehrani, F. R., Tahmasebi, S., Shafiee, A., & Hashemi, S. M. (2023) · Inflammopharmacology · doi:10.1007/s10787-022-01115-7 · Cited by 351 · see citing works
Exosomes, a New Star for Targeted Delivery
Chen, H., Wang, L., Zeng, X., Schwarz, H., Nanda, H. S., Peng, X., & Zhou, Y. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.751079 · Cited by 345 · see citing works
Non-viral vectors for RNA delivery
Yan, Y., Liu, X.-Y., Lu, A., Wang, X.-Y., Jiang, L.-X., & Wang, J.-C. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.01.008 · Cited by 332 · see citing works
Recent advances in exosome-mediated nucleic acid delivery for cancer therapy
Zhang, Y., Liu, Q., Zhang, X., Huang, H., Tang, S., Chai, Y., Xu, Z., Li, M., Chen, X., Liu, J., et al. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01472-z · Cited by 306 · see citing works
Zhu, Q., Ling, X., Yang, Y., Zhang, J., Li, Q., Niu, X., Hu, G., Chen, B., Li, H., Wang, Y., et al. (2019) · Advanced Science · doi:10.1002/advs.201801899 · Cited by 305 · see citing works
Song, H., Li, X., Zhao, Z., Jin, Q., Wang, Y., Cui, J., Weng, W., Cao, L., Chen, X., Hu, Y., et al. (2019) · Nano Letters · doi:10.1021/acs.nanolett.9b00287 · Cited by 303 · see citing works
Wan, T. Y., Zhong, J., Pan, Q., Zhou, T., Yuan, P., & Liu, X. (2022) · Science Advances · doi:10.1126/sciadv.abp9435 · Cited by 303 · see citing works
Exploiting the biogenesis of extracellular vesicles for bioengineering and therapeutic cargo loading
Rädler, J., Gupta, D., Zickler, A. M., & Andaloussi, S. E. (2023) · Molecular Therapy · doi:10.1016/j.ymthe.2023.02.013 · Cited by 292 · see citing works
The clinical potential of circulating microRNAs in obesity
Ji, C., & Guo, X. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0260-0 · Cited by 260 · see citing works
Huda, M. N., Nafiujjaman, M., Deaguero, I. G., Okonkwo, J., Hill, M. L., Kim, T. H., & Nurunnabi, M. (2021) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.1c00217 · Cited by 262 · see citing works
Designer Exosomes: A New Platform for Biotechnology Therapeutics
Jafari, D., Shajari, S., Jafari, R., Mardi, N., Gomari, H., Ganji, F., Moghadam, M. F., & Samadikuchaksaraei, A. (2020) · BioDrugs · doi:10.1007/s40259-020-00434-x · Cited by 251 · see citing works
The tremendous biomedical potential of bacterial extracellular vesicles
Xie, J., Li, Q., Haesebrouck, F., Hoecke, L. V., & Vandenbroucke, R. E. (2022) · Trends in biotechnology · doi:10.1016/j.tibtech.2022.03.005 · Cited by 245 · see citing works
Exosome-mediated delivery of gene vectors for gene therapy
Duan, L., Xu, L., Xu, X., Qin, Z., Zhou, X., Xiao, Y., Liang, Y., & Xia, J. (2021) · Nanoscale · doi:10.1039/d0nr07622h · Cited by 238 · see citing works
Self-citationDu, J., Wan, Z., Wang, C., Fan, L., Wei, M., Wang, D., & Hao, Q. (2021) · Theranostics · doi:10.7150/thno.59121 · Cited by 233 · see citing works
Self-citationChondrocyte-specific genomic editing enabled by hybrid exosomes for osteoarthritis treatment
Liang, Y., Xu, X., Xu, L., Iqbal, Z., Ouyang, K., Zhang, H., Wen, C., Duan, L., & Xia, J. (2022) · Theranostics · doi:10.7150/thno.69368 · Cited by 217 · see citing works
Extracellular vesicles as a drug delivery system: A systematic review of preclinical studies
de Castilla, P. E. M., Tong, L., Huang, C., Sofias, A. M., Pastorin, G., Chen, X. S., Storm, G., Schiffelers, R. M., & Wang, J. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.05.011 · Cited by 214 · see citing works
Overview and Update on Methods for Cargo Loading into Extracellular Vesicles
Han, Y., Jones, T. W., Dutta, S., Zhu, Y., Wang, X., Narayanan, S. P., Fagan, S. C., & Zhang, D. (2021) · Processes · doi:10.3390/pr9020356 · Cited by 213 · see citing works
da Silva, A. M., Lázaro‐Ibáñez, E., Gunnarsson, A., Dhande, A., Daaboul, G. G., Peacock, B., Osteikoetxea, X., Salmond, N., Friis, K. P., Shatnyeva, O., et al. (2021) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12130 · Cited by 191 · see citing works
Rational designs of in vivo CRISPR-Cas delivery systems
Xu, C., Chen, G., Luo, Y., Zhang, Y., Zhao, G., Lu, Z.-D., Czarna, A., Gu, Z., & Wang, J. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.11.005 · Cited by 185 · see citing works
Exosomes in atherosclerosis: performers, bystanders, biomarkers, and therapeutic targets
Wang, C., Li, Z., Liu, Y., & Yuan, L. (2021) · Theranostics · doi:10.7150/thno.56035 · Cited by 190 · see citing works
Self-citationThe role of Exosomal miRNAs in cancer
Li, C., Zhou, T., Chen, J., Li, R., Chen, H., Luo, S., Chen, D., Cai, C., & Li, W. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-021-03215-4 · Cited by 182 · see citing works
Ye, Y., Zhang, X., Xie, F., Xu, B., Xie, P., Yang, T., Shi, Q., Zhang, C., Zhang, Y., Chen, J., et al. (2020) · Biomaterials Science · doi:10.1039/d0bm00427h · Cited by 183 · see citing works
Chemically Modified Platforms for Better RNA Therapeutics
Shi, Y., Zhen, X., Zhang, Y., Li, Y., Koo, S., Saiding, Q., Kong, N., Liu, G., Chen, W., & Tao, W. (2024) · Chemical Reviews · doi:10.1021/acs.chemrev.3c00611 · Cited by 184 · see citing works
Yin, C., Han, Q., Xu, D., Zheng, B., Zhao, X., & Zhang, J. (2019) · OncoImmunology · doi:10.1080/2162402x.2019.1601479 · Cited by 178 · see citing works
Advancements and challenges in developing in vivo CAR T cell therapies for cancer treatment
Bui, T. A., Mei, H., Sang, R., Ortega, D., & Deng, W. (2024) · EBioMedicine · doi:10.1016/j.ebiom.2024.105266 · Cited by 168 · see citing works
Mi, B., Chen, L., Xiong, Y., Yang, Y., Panayi, A. C., Xue, H., Hu, Y., Yan, C., Hu, L., Xie, X., et al. (2022) · ACS Nano · doi:10.1021/acsnano.1c08284 · Cited by 170 · see citing works
Liang, Y., Iqbal, Z., Lu, J., Wang, J., Zhang, H., Chen, X., Duan, L., & Xia, J. (2023) · Molecular Therapy · doi:10.1016/j.ymthe.2022.10.008 · Cited by 162 · see citing works
Brown adipose tissue-derived exosomes mitigate the metabolic syndrome in high fat diet mice
Zhou, X., Li, Z., Qi, M., Zhao, P., Duan, Y., Yang, G., & Yuan, L. (2020) · Theranostics · doi:10.7150/thno.43968 · Cited by 157 · see citing works
Self-citationYang, J., Wu, S., Hou, L., Zhu, D., Yin, S., Yang, G., & Wang, Y. (2020) · Molecular Therapy Nucleic Acids · doi:10.1016/j.omtn.2020.06.013 · Cited by 154 · see citing works
Self-citationHan, X., Alu, A., Liu, H., Shi, Y., Wei, X., Cai, L., & Wei, Y. (2022) · Bioactive Materials · doi:10.1016/j.bioactmat.2022.01.011 · Cited by 159 · see citing works
The Role of Exosomal microRNAs and Oxidative Stress in Neurodegenerative Diseases
Wang, X., Zhou, Y., Gao, Q., Ping, D., Wang, Y., Wu, W., Xu, L., Fang, Y., Zhang, J., & Shao, A. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/3232869 · Cited by 149 · see citing works
Exosome for mRNA delivery: Strategies and therapeutic applications
Iqbal, Z., Rehman, K., Mahmood, A., Shabbir, M., Liang, Y., Duan, L., & Zeng, H. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02634-x · Cited by 144 · see citing works
Extracellular vesicles: Emerging tools as therapeutic agent carriers
Liu, S., Wu, X., Chandra, S., Lyon, C. J., Ning, B., Jiang, L., Fan, J., & Hu, Y. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.05.002 · Cited by 146 · see citing works
Extracellular vesicle-based Nanotherapeutics: Emerging frontiers in anti-inflammatory therapy
Tang, T., Wang, B., Lv, L., & Liu, B. (2020) · Theranostics · doi:10.7150/thno.47865 · Cited by 134 · see citing works
Bu, T., Li, Z., Hou, Y., Sun, W., Zhang, R., Zhao, L., Wei, M., Yang, G., & Yuan, L. (2021) · Theranostics · doi:10.7150/thno.64229 · Cited by 128 · see citing works
Self-citationEngineering therapeutical extracellular vesicles for clinical translation
Ma, Y., Dong, S., Grippin, A., Teng, L., Lee, A. S., Kim, B. Y. S., & Jiang, W. (2024) · Trends in biotechnology · doi:10.1016/j.tibtech.2024.08.007 · Cited by 126 · see citing works
CRISPR/Cas9: Principle, Applications, and Delivery through Extracellular Vesicles
Horodecka, K., & Düchler, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22116072 · Cited by 130 · see citing works
Barman, B., Sung, B. H., Krystofiak, E., Ping, J., Ramirez, M. A., Millis, B. A., Allen, R. M., Prasad, N., Chetyrkin, S. V., Calcutt, M. W., et al. (2022) · Developmental Cell · doi:10.1016/j.devcel.2022.03.012 · Cited by 125 · see citing works
Gangadaran, P., & Ahn, B. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12050442 · Cited by 118 · see citing works
Exosomes as drug delivery vehicle and contributor of resistance to anticancer drugs
Chinnappan, M., Srivastava, A., Amreddy, N., Razaq, M., Pareek, V., Ahmed, R. A., Mehta, M., Peterson, J. E. G., Munshi, A., & Ramesh, R. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.05.004 · Cited by 116 · see citing works
Nanomedicine to target multidrug resistant tumors
Lepeltier, É., Rijo, P. M., Rizzolio, F., Popovtzer, R., Petrikaitė, V., Assaraf, Y. G., & Passirani, C. (2020) · Drug Resistance Updates · doi:10.1016/j.drup.2020.100704 · Cited by 116 · see citing works
The cancer exosomes: Clinical implications, applications and challenges
Tang, Z., Li, D., Hou, S., & Zhu, X. M. (2019) · International Journal of Cancer · doi:10.1002/ijc.32762 · Cited by 115 · see citing works
Zhao, S., Xiu, G., Wang, J., Wen, Y., Lu, J., Wu, B., Wang, G., Yang, D., Ling, B., Du, D., et al. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-02086-9 · Cited by 109 · see citing works
Exosome-based <i>Ldlr</i> gene therapy for familial hypercholesterolemia in a mouse model
Li, Z., Zhao, P., Zhang, Y., Wang, J., Wang, C., Liu, Y., Yang, G., & Yuan, L. (2021) · Theranostics · doi:10.7150/thno.49874 · Cited by 108 · see citing works
Self-citationEngineered Extracellular Vesicles as a Reliable Tool in Cancer Nanomedicine
Susa, F., Limongi, T., Dumontel, B., Vighetto, V., & Cauda, V. (2019) · Cancers · doi:10.3390/cancers11121979 · Cited by 100 · see citing works
Engineered Extracellular Vesicles: Tailored-Made Nanomaterials for Medical Applications
Man, K., Brunet, M. Y., Jones, M., & Cox, S. C. (2020) · Nanomaterials · doi:10.3390/nano10091838 · Cited by 105 · see citing works
Programming assembly of biomimetic exosomes: An emerging theranostic nanomedicine platform
Xu, X., Xu, L., Wen, C., Xia, J., Zhang, Y., & Liang, Y. (2023) · Materials Today Bio · doi:10.1016/j.mtbio.2023.100760 · Cited by 101 · see citing works
Extracellular vesicles versus lipid nanoparticles for the delivery of nucleic acids
Bader, J., Brigger, F., & Leroux, J. (2024) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2024.115461 · Cited by 103 · see citing works
Extracellular vesicles in cancer nanomedicine
Tarasov, V. V., Svistunov, A. A., Chubarev, V. N., Dostdar, S. A., Sokolov, A. V., Brzecka, A., Sukocheva, O., Neganova, M. E., Klochkov, S. G., Somasundaram, S. G., et al. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.08.017 · Cited by 97 · see citing works
Wang, Z., Mo, H., He, Z., Chen, A., & Cheng, P. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113480 · Cited by 97 · see citing works
The roles of exosomes in cancer drug resistance and its therapeutic application
Li, S., Yi, M., Dong, B., Jiao, Y., Luo, S., & Wu, K. (2020) · Clinical and Translational Medicine · doi:10.1002/ctm2.257 · Cited by 96 · see citing works
CRISPR/Cas9 Delivery System Engineering for Genome Editing in Therapeutic Applications
Cheng, H., Zhang, F., & Ding, Y. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13101649 · Cited by 98 · see citing works
Reprogramming the tumor microenvironment by genome editing for precision cancer therapy
Liu, K., Cui, J., Zhan, Y., Ouyang, Q., Lu, Q., Yang, D., Li, X., & Yin, J. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01561-5 · Cited by 95 · see citing works
Song, H., Chen, X., Hao, Y., Wang, J., Xie, Q., & Wang, X. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01638-9 · Cited by 96 · see citing works
Engineering nanoparticle toolkits for mRNA delivery
Sun, B. F., Wu, W., Narasipura, E. A., Ma, Y., Yu, C., Fenton, O. S., & Song, H. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115042 · Cited by 93 · see citing works
Targeting miRNA by CRISPR/Cas in cancer: advantages and challenges
Hussen, B. M., Rasul, M. F., Abdullah, S. R., Hidayat, H. J., Faraj, G. S. H., Ali, F. A., Salihi, A. B., Baniahmad, A., Ghafouri‐Fard, S., Rahman, M., et al. (2023) · Military Medical Research · doi:10.1186/s40779-023-00468-6 · Cited by 97 · see citing works
Zhang, H., Yan, W.-J., Wang, J., Xie, S.-Q., Tao, W., Lee, C.-W., Zhang, X., Zhang, G.-Y., Liu, Y.-F., Wei, D., et al. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.04.009 · Cited by 88 · see citing works
Organically derived exosomes as carriers of anticancer drugs and imaging agents for cancer treatment
Srivastava, A., Rathore, S., Munshi, A., & Ramesh, R. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.02.020 · Cited by 88 · see citing works
Zhao, X., Fu, L., Zou, H., He, Y., Pan, Y., Ye, L., Huang, Y., Fan, W., Zhang, J., Ma, Y., et al. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-01886-3 · Cited by 87 · see citing works
Strategies for Engineering of Extracellular Vesicles
Aleksandrovna, D. A., Emene, C. C., Barlev, N. A., & Gomzikova, M. O. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713247 · Cited by 83 · see citing works
Therapeutic Applications of Nanomedicine: Recent Developments and Future Perspectives
Rehan, F., Zhang, M., Fang, J. Q., & Greish, K. F. (2024) · Molecules · doi:10.3390/molecules29092073 · Cited by 91 · see citing works
Extracellular vesicles in cancer´s communication: messages we can read and how to answer
Semerádtová, A., Liegertová, M., Herma, R., Čapková, M., Brignole, C., & Zotto, G. D. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02282-1 · Cited by 89 · see citing works
Exosome‐mediated delivery of miR‐204‐5p inhibits tumor growth and chemoresistance
Yao, S., Yin, Y., Jin, G., Li, D., Li, M., Hu, Y., Feng, Y., Liu, Y., Bian, Z., Wang, X., et al. (2020) · Cancer Medicine · doi:10.1002/cam4.3248 · Cited by 82 · see citing works
CRISPR-Cas9 delivery strategies with engineered extracellular vesicles
Lu, Y., Godbout, K., Lamothe, G., & Tremblay, J. P. (2023) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2023.102040 · Cited by 87 · see citing works
A Novel Peptide-Equipped Exosomes Platform for Delivery of Antisense Oligonucleotides
Xu, H., Liao, C., Liang, S., & Ye, B. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c00016 · Cited by 80 · see citing works
Functional Extracellular Vesicles for Regenerative Medicine
Kim, H. Y., Kwon, S., Um, W., Shin, S., Kim, C. H., Park, J. H., & Kim, B. (2022) · Small · doi:10.1002/smll.202106569 · Cited by 80 · see citing works
Biomass-derived carbon anodes for sodium-ion batteries
Huang, S., Qiu, X., Wang, C., Zhong, L., Zhang, Z.-H., Yang, S.-S., Sun, S., Yang, D.-J., & Zhang, W. (2023) · New Carbon Materials · doi:10.1016/s1872-5805(23)60718-8 · Cited by 80 · see citing works
Song, Z., Tao, Y., Liu, Y., & Li, J. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1444437 · Cited by 79 · see citing works
Extracellular Vesicles – Advanced Nanocarriers in Cancer Therapy: Progress and Achievements
Huyan, T., Li, H., Peng, H., Chen, J., Yang, R., Zhang, W., & Li, Q. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s238099 · Cited by 74 · see citing works
Multiplexed strategies toward clinical translation of extracellular vesicles
Song, J., Song, B., Yuan, L., & Yang, G. (2022) · Theranostics · doi:10.7150/thno.75899 · Cited by 78 · see citing works
Self-citationLiang, Y., Iqbal, Z., Wang, J., Xu, L., Xu, X., Ouyang, K., Zhang, H., Lu, J., Duan, L., & Xia, J. (2022) · Biomaterials Science · doi:10.1039/d2bm00480a · Cited by 72 · see citing works
Exosome based miRNA delivery strategy for disease treatment
Fang, Z., Zhang, X., Huang, H. W., & Wu, J. (2021) · Chinese Chemical Letters · doi:10.1016/j.cclet.2021.11.050 · Cited by 72 · see citing works
Extracellular vesicle‐based nucleic acid delivery
Lu, M., Shao, W., Xing, H., & Huang, Y. (2023) · Interdisciplinary medicine · doi:10.1002/inmd.20220007 · Cited by 73 · see citing works
Nanomaterials for mRNA ‐based therapeutics: Challenges and opportunities
Li, D., Liu, Q., Yang, M., Xu, H., Zhu, M., Zhang, Y., Xu, J., Tian, C., Yao, J., Wang, L., et al. (2023) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10492 · Cited by 71 · see citing works
Converting extracellular vesicles into nanomedicine: loading and unloading of cargo
Joshi, B. S., Ortíz-Rios, D., & Zuhorn, I. S. (2021) · Materials Today Nano · doi:10.1016/j.mtnano.2021.100148 · Cited by 70 · see citing works
Extracellular vesicles for the delivery of gene therapy
Ianni, E. D., Obuchi, W., Breyne, K., & Breakefield, X. O. (2025) · Nature Reviews Bioengineering · doi:10.1038/s44222-025-00277-7 · Cited by 72 · see citing works
Nanotechnology based CRISPR/Cas9 system delivery for genome editing: Progress and prospect
Deng, H., Huang, W., & Zhang, Z. (2019) · Nano Research · doi:10.1007/s12274-019-2465-x · Cited by 69 · see citing works
Engineered extracellular vesicles for bone therapy
Jiang, Y., Li, J., Xu, X. J., Yin, Z., Xu, K., & Su, J. (2022) · Nano Today · doi:10.1016/j.nantod.2022.101487 · Cited by 68 · see citing works
Dave, K. M., Pinky, P. P., & Manickam, D. S. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114068 · Cited by 78 · see citing works
Exosome-mediated delivery of siRNA molecules in cancer therapy: triumphs and challenges
Ubanako, P., Mirza, S., Ruff, P., & Penny, C. (2024) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2024.1447953 · Cited by 68 · see citing works
Analysis of extracellular vesicles as emerging theranostic nanoplatforms
Xing, Y., Cheng, Z., Wang, R., Lv, C., James, T. D., & Yu, F. (2020) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2020.213506 · Cited by 67 · see citing works
Standardization Approaches for Extracellular Vesicle Loading with Oligonucleotides and Biologics
Roerig, J., & Schulz‐Siegmund, M. (2023) · Small · doi:10.1002/smll.202301763 · Cited by 67 · see citing works
Engineering of MSC-Derived Exosomes: A Promising Cell-Free Therapy for Osteoarthritis
Cheng, J., Sun, Y., Ma, Y., Ao, Y., Hu, X., & Meng, Q. (2022) · Membranes · doi:10.3390/membranes12080739 · Cited by 68 · see citing works
CRISPR-Cas9-Based Technology and Its Relevance to Gene Editing in Parkinson’s Disease
Rahman, M. U., Bilal, M., Shah, J. A., Kaushik, A. K., Teissèdre, P., & Kujawska, M. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14061252 · Cited by 65 · see citing works
Hepatic stellate cell reprogramming via exosome-mediated CRISPR/dCas9-VP64 delivery
Luo, N., Li, J., Chen, Y., Xu, Y., Wei, Y., Lu, J., & Dong, R. (2020) · Drug Delivery · doi:10.1080/10717544.2020.1850917 · Cited by 63 · see citing works
Sun, W., Xing, C., Zhao, L., Zhao, P., Yang, G., & Yuan, L. (2020) · Molecular Therapy Nucleic Acids · doi:10.1016/j.omtn.2020.03.016 · Cited by 62 · see citing works
Self-citationGuo, Y., Wan, Z., Zhao, P., Wei, M., Liu, Y., Bu, T., Sun, W., Li, Z., & Yuan, L. (2021) · Journal of Nanobiotechnology · doi:10.1186/s12951-021-01145-3 · Cited by 60 · see citing works
Self-citationThe in vivo fate and targeting engineering of crossover vesicle-based gene delivery system
Jiang, X., Zhang, T., & Gao, J. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114324 · Cited by 59 · see citing works
- Authors
- Li, Z., Zhou, X., Wei, M., Gao, X., Zhao, L., Shi, R., Sun, W., Duan, Y., Yang, G., & Yuan, L.
- Affiliations
- Tang Du Hospital (CN)
- Air Force Medical University (CN)
- Corresponding author
- Yang, Guodong
- Yuan, Lijun
- Venue
- Nano Letters
- Publisher
- American Chemical Society (ACS)
- Published
- 2018-12-05
- Volume
- 19
- Issue
- 1
- Pages
- 19-28
- ISSN
- 1530-6984 (ISSN-L)
- 1530-6992
- OpenAlex
- W2903480993
- Cited by
- 318
- References
- 34
- Citations by year
- 2026: 27 · 2025: 33 · 2024: 54 · 2023: 56 · 2022: 55 · 2021: 43 · 2020: 36 · 2019: 13 · 2016: 1
- FWCI
- 8.18
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nano Letters (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (81671690, 81871357, 31771507)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Keywords
- engineered exosomes, RNA delivery, microRNA delivery, CRISPR/dCas9, miR-155, AU-rich elements, RNA-binding proteins, gene therapy vectors
- MeSH terms
- ELAV-Like Protein 1, Animals, Cell Line, Humans, RNA-Binding Proteins, Gene Transfer Techniques, RNA, Small Interfering, MicroRNAs, Mice, Exosomes, Tetraspanin 29, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
